FDA Webview
X
latest-news

Two Polsinelli attorneys say the Supreme Court’s refusal to hear an appeal in a labeling case helps manufacturers argue for preemption.

latest-news

Philips Respironics recalls its Trilogy Evo ventilator and all software versions, except 1.05.06.00, due to the device’s potential for sudden loss of ventilation.

LATEST NEWS

View All
motusgi
SCOTUS Won’t Hear False Labeling Case

Two Polsinelli attorneys say the Supreme Court’s refusal to hear an appeal in a labeling case helps manufacturers argue for preemption.

motusgi
Philips Respironics Recalls Trilogy Evo Ventilators

Philips Respironics recalls its Trilogy Evo ventilator and all software versions, except 1.05.06.00, due to the device’s potential for sudden loss of ventilation.

motusgi
Woodcock Plays Advisory Role at Patient Nonprofit

Patient nonprofit group Haystack Project confirms that former FDA principal deputy commissioner Janet Woodcock is playing an advisory role in its drug development activities.

motusgi
PhRMA Changes for Data Committee Guide

PhRMA gives FDA general and specific comments on a draft guidance on using data monitoring committees in clinical trials.

newsletter-first

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Animal Drugs

View All
medical-devices
Read More
Guide on Animal Drug Mfg. Batches

FDA releases a draft guidance entitled “Manufacture of Batches in Support of Original NADAs, ANADAs, and CNADAs.”

medical-devices
Read More
2 Veterinary Medicine Guidances Published

The Center for Veterinary Medicine issues two guidances on data element submission.

medical-devices
Read More
Animal Drug API GMP Guidance

FDA publishes a comprehensive Veterinary International Conference on Harmonization guidance on good manufacturing practice for animal drug APIs.

medical-devices
Read More
Animal MUMS Drug Guidance

FDA publishes a guidance to assist sponsors in seeking approval of new animal drugs for minor uses or minor species.

Biologics

View All
medical-devices
Read More
GSK BLA Accepted for Meningococcal Vaccine

FDA accepts for review a GSK BLA for its 5-in-1 meningococcal ABCWY vaccine candidate.

medical-devices
Read More
Enlivex Mixed Results of Sepsis Cell Therapy

Enlivex Therapeutics reports mixed results from its Phase 2 study of Allocetra in patients with sepsis.

medical-devices
Read More
Mixed Data on Colon Cancer Vaccine

Gritstone Bio reports mixed data from an ongoing Phase 2 portion of a Phase 2/3 study evaluating Granite, a personalized neoantigen cancer vaccine for...

medical-devices
Read More
Eisai sBLA for Monthly Alzheimer’s Maintenance

Eisai files a supplemental BLA for monthly Leqembi (lecanemab-irmb) intravenous maintenance dosing in Alzheimer’s disease patients.

FDA General

View All
medical-devices
Read More
Califf in Hot Seat at 4/11 Oversight Hearing

The House Committee on Oversight and Accountability ratchets up political pressure on FDA by requesting commissioner Robert Califf’s testimony at a 4/...

medical-devices
Read More
Poll Backs FDA Status Quo in Approving Products

In the wake of this week’s U.S. Supreme Court oral arguments on the abortion drug mifepristone, a new Axios/Ipsos poll finds that most Americans say t...

medical-devices
Read More
Weiner Moves to Foreign Inspections Office

FDA Office of Combination Products associate director for policy John Weiner moves to Office of Global Operations director, where he will oversee the ...

medical-devices
Read More
GAO Report Hits FDA on Investigator Retention

A new Government Accountability Office report says FDA needs to evaluate its recruitment and retention efforts to support and maintain its investigato...

newsletter-second

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Federal Register

View All
motusgi
Read More
Priority Review Voucher to Orchard Therapeutics

Federal Register notice: FDA issues a priority review voucher to Orchard Therapeutics for its rare p...

motusgi
Read More
Info Collection on Drug Expedited Programs

Federal Register notice: FDA sends to OMB an information collection extension entitled “Expedited Pr...

motusgi
Read More
Clinical Trial Innovation Center Established

CDER establishes the Center for Clinical Trial Innovation to support innovative approaches to clinic...

motusgi
Read More
Kemstro Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that UCB’s Kemstro (baclofen) orally disintegrating tablets,...

Human Drugs

View All
motusgi
Read More
SCOTUS Won’t Hear False Labeling Case

Two Polsinelli attorneys say the Supreme Court’s refusal to hear an appeal in a labeling case helps ...

motusgi
Read More
Woodcock Plays Advisory Role at Patient Nonprofit

Patient nonprofit group Haystack Project confirms that former FDA principal deputy commissioner Jane...

motusgi
Read More
PhRMA Changes for Data Committee Guide

PhRMA gives FDA general and specific comments on a draft guidance on using data monitoring committee...

motusgi
Read More
New PMI Form Explained

CDER Office of Medical Policy regulatory counsel Christopher Diamant explains why the new Patient Me...

Marketing

View All
motusgi
Read More
Methodological Rigor Info May Help Promotions: OPDP

CDER Office of Prescription Drug Promotion researchers say disclosing methodological rigor in commun...

motusgi
Read More
Disease Awareness Ads Can Confuse: FDA Study

CDER Office of Prescription Drug Promotion research demonstrates that consumers may be confused and ...

motusgi
Read More
Digital Drug Marketing Workshop Themes

A Duke-Margolis Institute for Health Policy report on an FDA-funded virtual workshop on drug digital...

motusgi
Read More
Industry Faults FDA Research on DTC ‘Implied Claims’

Industry stakeholders question the usefulness and design of proposed CDER Office of Prescription Dru...

Medical Devices

View All
motusgi
Read More
Philips Respironics Recalls Trilogy Evo Ventilators

Philips Respironics recalls its Trilogy Evo ventilator and all software versions, except 1.05.06.00,...

motusgi
Read More
FDA Reports on Device Safety, Innovation

CDRH releases reports on its commitment to medical device innovation and safety.

motusgi
Read More
Boston Scientific Recalls Obsidio Embolic

Boston Scientific recalls its embolic agent Obsidio Embolic after an investigation finds that its us...

motusgi
Read More
Sen. Cassidy Challenges FDA on CDS Oversight

Sen. Bill Cassidy says FDA needs to explain why it ignored Congress and expanded its oversight over ...